The effect on blood pressure of a monophasic oral contraceptive containing ethinylestradiol and gestodene.
Contraception
; 51(6): 335-9, 1995 Jun.
Article
em En
| MEDLINE
| ID: mdl-7554972
ABSTRACT
To obtain an overview of the effect of monophasic gestodene on blood pressure and to determine the frequency of "OC elevated BP/hypertension," the results of blood pressure monitoring from four clinical studies of contraceptive efficacy and safety have been retrospectively analyzed. A total of 1930 women took part in the studies, which recorded BP for up to 24 cycles. Analysis of results revealed that 97 women (5.0%) showed an increase in blood pressure from previously normal to elevated values while taking monophasic gestodene, with only 26 (1.35%) fulfilling the criteria of "OC elevated BP/hypertension." Only four women dropped out of the trials due to hypertensive blood pressure values, while 67 women (3.5%) experienced a normalization of previously elevated blood pressure measurements. In conclusion, this analysis has confirmed that gestodene has a negligible effect on blood pressure, with increased BP a relatively rare event.
ABSTRACT
PIP Schering AG (manufacturer of a monophasic oral contraceptive [OC] containing 75 mcg gestodene plus 30 mcg ethinyl estradiol) in Berlin, Germany, conducted a retrospective analysis of blood pressure measurements from 4 clinical trials of the contraceptive efficacy and safety of monophasic gestodene to examine gestodene's effect on blood pressure and the incidence of OC-related blood pressure/ hypertension. (OC-related blood pressure/hypertension is defined as women with neither history of hypertension nor elevated blood pressure before OC use develop increased blood pressure or hypertension that is reversible once OC use ceases.) The clinical trials recorded the blood pressure of 1930 women for up to 24 cycles. Most women (89.9%) experienced no change in their blood pressure during OC use. 97 women (5%) experienced an increase in blood pressure. 26 women (1.35%) had OC-elevated blood pressure/hypertension. Four women left the trials due to hypertension. 67 women (3.5%) who had elevated blood pressure before OC use attained normalization of blood pressure during OC use. These results show that the gestodene-containing OC had an insignificant effect on blood pressure and that elevated blood pressure rarely occurred.
Palavras-chave
Biology; Blood Pressure; Contraception; Contraceptive Agents; Contraceptive Agents, Estrogen; Contraceptive Agents, Female; Contraceptive Agents, Progestin; Contraceptive Methods; Developed Countries; Diseases; Ethinyl Estradiol; Europe; Family Planning; Germany; Gestodene; Hemic System; Hypertension; Oral Contraceptives; Oral Contraceptives, Combined; Physiology; Research Methodology; Retrospective Studies; Studies; Vascular Diseases; Western Europe
Buscar no Google
Bases de dados:
MEDLINE
Assunto principal:
Pressão Sanguínea
/
Anticoncepcionais Orais
/
Anticoncepcionais Orais Combinados
/
Congêneres do Estradiol
/
Etinilestradiol
/
Norpregnenos
Tipo de estudo:
Observational_studies
/
Risk_factors_studies
Limite:
Adolescent
/
Adult
/
Female
/
Humans
/
Middle aged
Idioma:
En
Revista:
Contraception
Ano de publicação:
1995
Tipo de documento:
Article
País de afiliação:
Alemanha